Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

AbbVie’s Cariprazine (VRAYLAR®) Met Primary Endpoint in Phase 3 Study as an Adjunctive …,

NORTH CHICAGO, Ill., Oct. 29, 2021 /PRNewswire/ — AbbVie(NYSE: ABBV) today announced top-line results from two Phase 3 clinical trials, …, NORTH CHICAGO, Ill., Oct. 29, 2021 /PRNewswire/ — AbbVie(NYSE: ABBV) today announced top-line results from two Phase 3 clinical trials, …, Read More

Scroll to Top